Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

Effect of a single pre-operative 125 mg dose of methylprednisolone on postoperative delirium in hip fracture patients; a randomised, double-blind, placebo-controlled trial

Research output: Contribution to journalJournal articleResearchpeer-review

DOI

  1. A difficulty with the DIFFMASK score is the difficult statistics - a reply

    Research output: Contribution to journalLetterResearchpeer-review

  2. Pre-operative methylprednisolone and postoperative delirium after hip fracture surgery - a reply

    Research output: Contribution to journalLetterResearchpeer-review

  3. The DIFFMASK score for predicting difficult facemask ventilation: a cohort study of 46,804 patients

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. An international consensus statement on the management of postoperative anaemia after major surgical procedures

    Research output: Contribution to journalReviewResearchpeer-review

View graph of relations

Postoperative delirium is common after hip fracture surgery, and may have a neuro-inflammatory cause. We conducted a single-centre, randomised, double-blind, placebo-controlled trial of 117 older hip fracture patients to see if a single, pre-operative intravenous dose of 125 mg methylprednisolone could reduce the severity and/or incidence of postoperative delirium, assessed using the Confusion Assessment Method delirium severity score. Modified intention-to-treat analysis found no significant difference in our primary outcome, median (IQR [range]) cumulative Confusion Assessment Method delirium severity score over the first three postoperative days between the methylprednisolone and placebo groups (1 (0-6 [0-39]) vs. 2 (0-10 [0-32]), p = 0.294). Both the prevalence of postoperative delirium (Confusion Assessment Method delirium severity score ≥ 5, 10/59 vs. 19/58, p = 0.048) and the median (IQR [range]) cumulated postoperative (by day 3) fatigue scores (5 (2-6 [0-11]) vs. 6 (4-8 [0-16]), p = 0.008) were significantly lower in the methylprednisolone compared with the placebo group. There were no significant between-group differences in the rate of completing physiotherapy, postoperative pain, the administration of antipsychotic drugs, infection, length of inpatient stay or 30- and 90-day mortality. No major adverse reactions related to methylprednisolone were recorded. We conclude that a single, pre-operative dose of 125 mg methylprednisolone does not reduce the severity of postoperative delirium, but may reduce both the prevalence of delirium and the severity of fatigue after hip fracture surgery in older patients, enabling remobilisation and recovery.

Original languageEnglish
JournalAnaesthesia
Volume73
Issue number11
Pages (from-to)1353-1360
ISSN0003-2409
DOIs
Publication statusPublished - Nov 2018

ID: 55095198